Stockreport

MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Announce Initiation of First Dosing in Phase I/II Clinical Trial of JR-446 for Mucopolysaccharidosis Type IIIB in Japan [Yahoo! Finance...

MEDIPAL HLDGS UNSP/ADR  (MAHLY) 
PDF TOKYO & HYOGO, Japan, December 05, 2024 BUSINESS WIRE MEDIPAL HOLDINGS CORPORATION (TSE 7459, MEDIPAL) and JCR Pharmaceuticals Co., Ltd. (TSE 4552, JCR) today announced [Read more]